Atlas Trials

Multi-Centre, Prospective, Non-Interventional Study to Intensively Monitor the Safety of Sintilimab in Clinical Practice Among Chinese Patients

Clinical trial NCT04840355 · RECRUITING

Trial details

NCT number
NCT04840355
Sponsor
Guohui Li
Status
RECRUITING
Study type
OBSERVATIONAL
Immune Related Adverse EventsPD-1
Start date
2021-02-26
Primary completion
2025-11-14
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.